134 related articles for article (PubMed ID: 19032800)
1. Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse.
Gobbato N; Rachid M; Perdigón G
J Dairy Res; 2008 Nov; 75(4):497-504. PubMed ID: 19032800
[TBL] [Abstract][Full Text] [Related]
2. Role of yoghurt in the prevention of colon cancer.
Perdigón G; de Moreno de LeBlanc A; Valdez J; Rachid M
Eur J Clin Nutr; 2002 Aug; 56 Suppl 3():S65-8. PubMed ID: 12142967
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
4. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.
Laverny G; Penna G; Vetrano S; Correale C; Nebuloni M; Danese S; Adorini L
Immunol Lett; 2010 Jun; 131(1):49-58. PubMed ID: 20350569
[TBL] [Abstract][Full Text] [Related]
7. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases.
Nones K; Dommels YE; Martell S; Butts C; McNabb WC; Park ZA; Zhu S; Hedderley D; Barnett MP; Roy NC
Br J Nutr; 2009 Jan; 101(2):169-81. PubMed ID: 18761777
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Aharoni R; Kayhan B; Brenner O; Domev H; Labunskay G; Arnon R
J Pharmacol Exp Ther; 2006 Jul; 318(1):68-78. PubMed ID: 16624971
[TBL] [Abstract][Full Text] [Related]
10. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.
Katchar K; Kelly CP; Keates S; O'brien MJ; Keates AC
Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1263-71. PubMed ID: 17272517
[TBL] [Abstract][Full Text] [Related]
11. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.
Dieleman LA; Peña AS; Meuwissen SG; van Rees EP
Scand J Gastroenterol Suppl; 1997; 223():99-104. PubMed ID: 9200314
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease.
Godoi DF; Cardoso CR; Ferraz DB; Provinciatto PR; Cunha FQ; Silva JS; Voltarelli JC
Bone Marrow Transplant; 2010 Oct; 45(10):1562-71. PubMed ID: 20228850
[TBL] [Abstract][Full Text] [Related]
14. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
15. Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model.
de Moreno de LeBlanc A; Perdigón G
Biocell; 2005 Apr; 29(1):15-24. PubMed ID: 15954463
[TBL] [Abstract][Full Text] [Related]
16. Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells.
Suzuki K; Kawauchi Y; Palaniyandi SS; Veeraveedu PT; Fujii M; Yamagiwa S; Yoneyama H; Han GD; Kawachi H; Okada Y; Ajioka Y; Watanabe K; Hosono M; Asakura H; Aoyagi Y; Narumi S
Pathol Int; 2007 Jul; 57(7):413-20. PubMed ID: 17587240
[TBL] [Abstract][Full Text] [Related]
17. Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease.
Sun Y; Wu XX; Yin Y; Gong FY; Shen Y; Cai TT; Zhou XB; Wu XF; Xu Q
Biochem Pharmacol; 2010 Jan; 79(2):229-38. PubMed ID: 19698701
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 7-carboxymethyloxy-3',4',5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease.
Kim EJ; Chung MY; Chung HJ; Son MW; Kwon JW; Yoo M; Lee MG
J Pharm Pharmacol; 2006 Jan; 58(1):27-35. PubMed ID: 16393461
[TBL] [Abstract][Full Text] [Related]
19. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats.
Prakash A; Medhi B; Avti PK; Saikia UN; Pandhi P; Khanduja KL
Phytother Res; 2008 Nov; 22(11):1511-9. PubMed ID: 18688794
[TBL] [Abstract][Full Text] [Related]
20. 3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease.
di Paola R; Esposito E; Mazzon E; Caminiti R; Toso RD; Pressi G; Cozzocrea S
Free Radic Res; 2010 Jan; 44(1):74-89. PubMed ID: 19886745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
